Definitive Contract 75N91023C00042
Award Date
9/15/23
Potential Completion Date
9/14/27
Potential Value
$4.2M
Federal Agency
National Institutes of Health
Awardee
Trace Biosciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portland, OR 97239, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $4,091,483.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) to Feromics Inc., a small business located in Brookline, MA. The contract is for research and development (R&D) projects that will advance the mission and objectives of the Advanced Research Projects Agency for Health (ARPA-H) and the Small Business Innovation Research (SBIR) program. The contract covers six specific topic areas relating to affordable viral vector manufacturing, lymphatic...
This federal contract award, valued at $4,085,916.00, was made by the National Institutes of Health (NIH) to Triton Systems, Inc., a small business prime contractor, under the Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR) program. The contract is for the development of a smart cardiovascular monitoring implant, with a focus on creating a prototype medical device that can continuously track vascular health biomarkers like vessel occlusion, flow,...
This is a $396,190 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Tetraimaging LLC, a small disadvantaged business, to develop ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract was awarded on September 16, 2022 and is set to complete by December 15, 2023. The original solicitation, PHS-2022-1, announced by the NIH and CDC, sought small business...
This is a $247,568 Firm Fixed Price contract awarded by the National Cancer Institute (NCI) to Cellsight Technologies, Inc., a woman-owned small business. The contract is for research and development related to a novel PET imaging agent, [18F]F-ARAG, to assess response to cancer immunotherapies. This contract is part of NCI's Small Business Innovation Research (SBIR) program, which sets aside certain research and development contracts for small businesses. Cellsight Technologies has also...
This is a $1,995,174 Firm Fixed Price (FFP) Definitive Contract awarded by the National Cancer Institute (NCI) to Cellsight Technologies, Inc., a woman-owned small business. The contract is for SBIR Phase II research and development of the [18F]F-ARAG imaging agent to assess response to cancer immunotherapies in non-small cell lung cancer. This builds on a previous $300,000 SBIR Phase I contract from NCI to evaluate [18F]F-ARAG for predicting response to cancer immunotherapies. The contract...
This is a $300,000 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to Cellsight Technologies, Inc., a woman-owned small business, under the Small Business Innovation Research (SBIR) program. The purpose of the contract is to evaluate [18F]F-ARAG, a T cell-specific Positron Emission Tomography (PET) imaging agent, as a biomarker to predict response to cancer immunotherapies. This Phase I SBIR contract builds on a previous $2 million...
This is a $1,727,615.82 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ceres Nanosciences, Inc., a small business. The contract is for SBIR (Small Business Innovation Research) Phase II work on "Application of the Nanotrap Platform for Immunome Biomarker Preservation and Monitoring." This effort supports DARPA's mission in defense and national security by developing nanotechnology-enabled products and services to advance diagnostics and...
This is a $1,492,018.00 Firm Fixed Price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Scribe Biosciences, Inc., a small business, under the SBIR Program Phase II. The contract is for the development of "NEW PLATFORM TECHNOLOGIES FOR VIRAL AND THERAPEUTIC EVOLUTION ASSAYS." This contract is set aside for small businesses. Scribe Biosciences has previously received awards from the National Institutes of Health, National Science Foundation, and...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institutes of Health (NIH) to Netrias, LLC, a for-profit S-corporation specializing in artificial intelligence and data harmonization for the life sciences industry. The $3,133,507.00 fixed-price contract is for the development of "PATHENGINE II: A PLATFORM TO AUTOMATE THE INTEGRATION OF DATA TO PREDICT PATHOGENIC POTENTIAL", which involves creating an AI-driven platform to analyze and model...
This is a $398,714 firm fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Irai Technologies, LLC, a minority-owned small business. The contract is for the development of a flash dosimetry system based on ionizing radiation acoustic imaging, under Solicitation PHS-2023-1 for the NIH and CDC SBIR program. The goal is to contribute toward NCI mission needs and SBIR program objectives by stimulating technological innovation and fostering participation from small,...